| Affiliation: | 1. Department of Medical Oncology, Dana‐Farber Cancer Institute, Boston, Massachusetts;2. Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts;3. Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts;4. Department of Medical Oncology, INSERM Unit 981, Institute Gustave Roussy, Villejuif, France;5. Department of Pharmacoepidemiology, Brigham and Women's Hospital, Boston, Massachusetts;6. Department of Biostatistics and Computational Biology, Dana‐Farber Cancer Institute, Boston, Massachusetts |
